Literature DB >> 1351355

The use of diagnostic ultrasound in schistosomiasis--attempts at standardization of methodology. Cairo Working Group.

.   

Abstract

This paper summarises the conclusions of a workshop held in Cairo in 1990 to discuss the standardization of the use of diagnostic ultrasound in schistosomiasis. For epidemiological purposes, it is very important that ultrasound examinations should be carried out and recorded in a standardized way, in order to ensure that results obtained in different places and at different times can be compared. The workshop did not attempt to produce final recommendations, but it did make tentative proposals in a form suitable for field testing. The paper discusses the general problems involved in carrying out and recording ultrasound examinations in a standardized way. The special points involved in assessing lesions due to the three main forms of schistosomiasis are then considered in detail. Methodology that can be used in epidemiological work with large numbers of people is emphasised.

Entities:  

Mesh:

Year:  1992        PMID: 1351355     DOI: 10.1016/0001-706x(92)90020-x

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  17 in total

1.  Thrombocytemia as a predictor of portal hypertension in schistosomiasis.

Authors:  M R Souza; C F Toledo; D R Borges
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Advanced schistosomiasis reappeared after curing seemingly being cured for over 20 years and without known history of reexposure to Schistosoma japonicum.

Authors:  Haiyong Hua; Anhua Yin; Minhao Xu; Zhengyuan Zhou; Lu You; Hongxiong Guo
Journal:  Parasitol Res       Date:  2015-07-15       Impact factor: 2.289

Review 3.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

4.  Sonographic early findings in a case of bladder schistosomiasis.

Authors:  Dolores Ferrara; Francesco Esposito; Marco Di Serafino; Chiara Gullotto; Andrea Baglioni; Leonardo Martinelli; Massimo Zeccolini
Journal:  J Ultrasound       Date:  2018-07-12

5.  Gastrointestinal complications of schistosomiasis.

Authors:  T W Schafer; B R Hale
Journal:  Curr Gastroenterol Rep       Date:  2001-08

Review 6.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

7.  The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest China.

Authors:  Elizabeth J Carlton; Michelle Hsiang; Yi Zhang; Sarah Johnson; Alan Hubbard; Robert C Spear
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

8.  No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Authors:  Carole Eboumbou Moukoko; Nasureldin El Wali; O K Saeed; Qurashi Mohamed-Ali; Jean Gaudart; Alain J Dessein; Christophe Chevillard
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  High prevalence and morbidity of Schistosoma mansoni along the Albert Nile in Uganda.

Authors:  Emmanuel I Odongo-Aginya; Lorenz Grigull; Ulrich Schweigmann; Tom Loroni-Lakwo; Jochem H H Enrich; Bruno Gryseels; Ekkehard Doehring
Journal:  Afr Health Sci       Date:  2002-12       Impact factor: 0.927

10.  Use of ultrasonography to evaluate Schistosoma japonicum-related morbidity in children, Sichuan Province, China, 2000-2007.

Authors:  Michelle S Hsiang; Elizabeth J Carlton; Yi Zhang; Bo Zhong; Qiu Dongchuan; Pierre-Alain Cohen; Christopher C Stewart; Robert C Spear
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.